Interview with the Innovators
Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.
Dr. Boccia talks about the importance of controlling costs in the current environment and how the bioT3 testing approach can help compared to other options.
Dixie-Lee Esseltine, MD and George Mulligan, PhD discuss the challenges and gaps in the current standards of care of patients with multiple myeloma, including oral and intravenous treatment options in the frontline therapy setting.
Results 1 - 3 of 3
